Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk

Ajay Nehra, Graham Jackson, Martin Miner, Kevin L. Billups, Arthur L. Burnett, Jacques Buvat, Culley C. Carson, Glenn R. Cunningham, Irwin Goldstein, Andre T. Guay, Geoff Hackett, Robert A. Kloner, John Kostis, Piero Montorsi, Melinda Ramsey, Raymond C. Rosen, Richard Sadovsky, Allen D. Seftel, Charalambos Vlachopoulos, Frederick C W Wu

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Purpose: We established erectile dysfunction as an often neglected but valuable marker of cardiovascular risk, particularly in younger men and men with diabetes. We also reviewed evidence that lifestyle change, combined with informed prescribing of pharmacotherapies used to mitigate cardiovascular risk, can improve overall vascular health and sexual functioning in men with erectile dysfunction. Materials and Methods: We performed a PubMed® search for articles and guidelines pertinent to relationships between erectile dysfunction and cardiovascular disease, cardiovascular and all cause mortality, and pharmacotherapies for dyslipidemia and hypertension. The clinical guidance presented incorporates the current literature and the expertise of the multispecialty investigator group. Results: Numerous cardiovascular risk assessment tools exist but risk stratification remains challenging, particularly in patients at low or intermediate short-term risk. Erectile dysfunction has a predictive value for cardiovascular events that is comparable to or better than that of traditional risk factors. Interventional studies support lifestyle changes as a means of improving overall vascular health as well as sexual functioning. Statins, diuretics, β-blockers and renin-angiotensin system modifiers may positively or negatively affect erectile function. Furthermore, the phosphodiesterase type 5 inhibitors used to treat erectile dysfunction may have systemic vascular benefits. Conclusions: Erectile dysfunction treatment should be considered secondary to decreasing cardiovascular risk. However, informed prescribing may prevent worsening sexual function in men receiving pharmacotherapy for dyslipidemia and hypertension. As the first point of medical contact for men with erectile dysfunction symptoms, the primary care physician or urologist has a unique opportunity to identify those who require early intervention to prevent cardiovascular disease.

Original languageEnglish
Pages (from-to)2031-2038
Number of pages8
JournalJournal of Urology
Volume189
Issue number6
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Erectile Dysfunction
Risk Reduction Behavior
Blood Vessels
Dyslipidemias
Drug Therapy
Therapeutics
Life Style
Cardiovascular Diseases
Hypertension
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Phosphodiesterase 5 Inhibitors
Reproductive Health
Primary Care Physicians
Renin-Angiotensin System
Diuretics
PubMed
Research Personnel
Guidelines
Mortality
Health

Keywords

  • cardiovascular diseases
  • coronary artery disease
  • erectile dysfunction
  • penis
  • risk

ASJC Scopus subject areas

  • Urology

Cite this

Nehra, A., Jackson, G., Miner, M., Billups, K. L., Burnett, A. L., Buvat, J., ... Wu, F. C. W. (2013). Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. Journal of Urology, 189(6), 2031-2038. https://doi.org/10.1016/j.juro.2012.12.107

Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. / Nehra, Ajay; Jackson, Graham; Miner, Martin; Billups, Kevin L.; Burnett, Arthur L.; Buvat, Jacques; Carson, Culley C.; Cunningham, Glenn R.; Goldstein, Irwin; Guay, Andre T.; Hackett, Geoff; Kloner, Robert A.; Kostis, John; Montorsi, Piero; Ramsey, Melinda; Rosen, Raymond C.; Sadovsky, Richard; Seftel, Allen D.; Vlachopoulos, Charalambos; Wu, Frederick C W.

In: Journal of Urology, Vol. 189, No. 6, 06.2013, p. 2031-2038.

Research output: Contribution to journalArticle

Nehra, A, Jackson, G, Miner, M, Billups, KL, Burnett, AL, Buvat, J, Carson, CC, Cunningham, GR, Goldstein, I, Guay, AT, Hackett, G, Kloner, RA, Kostis, J, Montorsi, P, Ramsey, M, Rosen, RC, Sadovsky, R, Seftel, AD, Vlachopoulos, C & Wu, FCW 2013, 'Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk', Journal of Urology, vol. 189, no. 6, pp. 2031-2038. https://doi.org/10.1016/j.juro.2012.12.107
Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J et al. Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. Journal of Urology. 2013 Jun;189(6):2031-2038. https://doi.org/10.1016/j.juro.2012.12.107
Nehra, Ajay ; Jackson, Graham ; Miner, Martin ; Billups, Kevin L. ; Burnett, Arthur L. ; Buvat, Jacques ; Carson, Culley C. ; Cunningham, Glenn R. ; Goldstein, Irwin ; Guay, Andre T. ; Hackett, Geoff ; Kloner, Robert A. ; Kostis, John ; Montorsi, Piero ; Ramsey, Melinda ; Rosen, Raymond C. ; Sadovsky, Richard ; Seftel, Allen D. ; Vlachopoulos, Charalambos ; Wu, Frederick C W. / Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. In: Journal of Urology. 2013 ; Vol. 189, No. 6. pp. 2031-2038.
@article{24104539ecef440c825071e00e781239,
title = "Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk",
abstract = "Purpose: We established erectile dysfunction as an often neglected but valuable marker of cardiovascular risk, particularly in younger men and men with diabetes. We also reviewed evidence that lifestyle change, combined with informed prescribing of pharmacotherapies used to mitigate cardiovascular risk, can improve overall vascular health and sexual functioning in men with erectile dysfunction. Materials and Methods: We performed a PubMed{\circledR} search for articles and guidelines pertinent to relationships between erectile dysfunction and cardiovascular disease, cardiovascular and all cause mortality, and pharmacotherapies for dyslipidemia and hypertension. The clinical guidance presented incorporates the current literature and the expertise of the multispecialty investigator group. Results: Numerous cardiovascular risk assessment tools exist but risk stratification remains challenging, particularly in patients at low or intermediate short-term risk. Erectile dysfunction has a predictive value for cardiovascular events that is comparable to or better than that of traditional risk factors. Interventional studies support lifestyle changes as a means of improving overall vascular health as well as sexual functioning. Statins, diuretics, β-blockers and renin-angiotensin system modifiers may positively or negatively affect erectile function. Furthermore, the phosphodiesterase type 5 inhibitors used to treat erectile dysfunction may have systemic vascular benefits. Conclusions: Erectile dysfunction treatment should be considered secondary to decreasing cardiovascular risk. However, informed prescribing may prevent worsening sexual function in men receiving pharmacotherapy for dyslipidemia and hypertension. As the first point of medical contact for men with erectile dysfunction symptoms, the primary care physician or urologist has a unique opportunity to identify those who require early intervention to prevent cardiovascular disease.",
keywords = "cardiovascular diseases, coronary artery disease, erectile dysfunction, penis, risk",
author = "Ajay Nehra and Graham Jackson and Martin Miner and Billups, {Kevin L.} and Burnett, {Arthur L.} and Jacques Buvat and Carson, {Culley C.} and Cunningham, {Glenn R.} and Irwin Goldstein and Guay, {Andre T.} and Geoff Hackett and Kloner, {Robert A.} and John Kostis and Piero Montorsi and Melinda Ramsey and Rosen, {Raymond C.} and Richard Sadovsky and Seftel, {Allen D.} and Charalambos Vlachopoulos and Wu, {Frederick C W}",
year = "2013",
month = "6",
doi = "10.1016/j.juro.2012.12.107",
language = "English",
volume = "189",
pages = "2031--2038",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk

AU - Nehra, Ajay

AU - Jackson, Graham

AU - Miner, Martin

AU - Billups, Kevin L.

AU - Burnett, Arthur L.

AU - Buvat, Jacques

AU - Carson, Culley C.

AU - Cunningham, Glenn R.

AU - Goldstein, Irwin

AU - Guay, Andre T.

AU - Hackett, Geoff

AU - Kloner, Robert A.

AU - Kostis, John

AU - Montorsi, Piero

AU - Ramsey, Melinda

AU - Rosen, Raymond C.

AU - Sadovsky, Richard

AU - Seftel, Allen D.

AU - Vlachopoulos, Charalambos

AU - Wu, Frederick C W

PY - 2013/6

Y1 - 2013/6

N2 - Purpose: We established erectile dysfunction as an often neglected but valuable marker of cardiovascular risk, particularly in younger men and men with diabetes. We also reviewed evidence that lifestyle change, combined with informed prescribing of pharmacotherapies used to mitigate cardiovascular risk, can improve overall vascular health and sexual functioning in men with erectile dysfunction. Materials and Methods: We performed a PubMed® search for articles and guidelines pertinent to relationships between erectile dysfunction and cardiovascular disease, cardiovascular and all cause mortality, and pharmacotherapies for dyslipidemia and hypertension. The clinical guidance presented incorporates the current literature and the expertise of the multispecialty investigator group. Results: Numerous cardiovascular risk assessment tools exist but risk stratification remains challenging, particularly in patients at low or intermediate short-term risk. Erectile dysfunction has a predictive value for cardiovascular events that is comparable to or better than that of traditional risk factors. Interventional studies support lifestyle changes as a means of improving overall vascular health as well as sexual functioning. Statins, diuretics, β-blockers and renin-angiotensin system modifiers may positively or negatively affect erectile function. Furthermore, the phosphodiesterase type 5 inhibitors used to treat erectile dysfunction may have systemic vascular benefits. Conclusions: Erectile dysfunction treatment should be considered secondary to decreasing cardiovascular risk. However, informed prescribing may prevent worsening sexual function in men receiving pharmacotherapy for dyslipidemia and hypertension. As the first point of medical contact for men with erectile dysfunction symptoms, the primary care physician or urologist has a unique opportunity to identify those who require early intervention to prevent cardiovascular disease.

AB - Purpose: We established erectile dysfunction as an often neglected but valuable marker of cardiovascular risk, particularly in younger men and men with diabetes. We also reviewed evidence that lifestyle change, combined with informed prescribing of pharmacotherapies used to mitigate cardiovascular risk, can improve overall vascular health and sexual functioning in men with erectile dysfunction. Materials and Methods: We performed a PubMed® search for articles and guidelines pertinent to relationships between erectile dysfunction and cardiovascular disease, cardiovascular and all cause mortality, and pharmacotherapies for dyslipidemia and hypertension. The clinical guidance presented incorporates the current literature and the expertise of the multispecialty investigator group. Results: Numerous cardiovascular risk assessment tools exist but risk stratification remains challenging, particularly in patients at low or intermediate short-term risk. Erectile dysfunction has a predictive value for cardiovascular events that is comparable to or better than that of traditional risk factors. Interventional studies support lifestyle changes as a means of improving overall vascular health as well as sexual functioning. Statins, diuretics, β-blockers and renin-angiotensin system modifiers may positively or negatively affect erectile function. Furthermore, the phosphodiesterase type 5 inhibitors used to treat erectile dysfunction may have systemic vascular benefits. Conclusions: Erectile dysfunction treatment should be considered secondary to decreasing cardiovascular risk. However, informed prescribing may prevent worsening sexual function in men receiving pharmacotherapy for dyslipidemia and hypertension. As the first point of medical contact for men with erectile dysfunction symptoms, the primary care physician or urologist has a unique opportunity to identify those who require early intervention to prevent cardiovascular disease.

KW - cardiovascular diseases

KW - coronary artery disease

KW - erectile dysfunction

KW - penis

KW - risk

UR - http://www.scopus.com/inward/record.url?scp=84877607887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877607887&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2012.12.107

DO - 10.1016/j.juro.2012.12.107

M3 - Article

VL - 189

SP - 2031

EP - 2038

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6

ER -